Skip to main content
Quest Diagnostics

Genome Sequencing Detects a Balanced Pericentric Inversion With Breakpoints That Impact the DMD and Upstream Region of POU3F4 Genes

Genome Sequencing Detects a Balanced Pericentric Inversion With Breakpoints That Impact the DMD and Upstream Region of POU3F4 Genes

Authors: Chandrasekhar A, Mroczkowski HJ, Urraca N, Gross A, Bluske K, Thorpe E, Hagelstrom RT, Schonberg SA, Perry DL, Taft RJ, Kesari A

Citation: Am J Med Genet A. 2023 Nov 6. doi: 10.1002/ajmg.a.63462. Online ahead of print

Specialties: Genetics, Neurology

Related content

Conference Presentation
Genetic risk factors for pancreatitis: A retrospective analysis of 400 patients
Next-Generation Sequencing-Based Panel Testing Identifies Heterogeneous Genetic Etiologies of Short Stature
Audio Podcast
Growing as a Laboratory Partner

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.